Growth Hormone Treatment Completely Normalizes Adult Height and Improves Body Composition in Prader-Willi Syndrome: Experience from KIGS (Pfizer International Growth Database)

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Hormone Research in Paediatrics

• Publication date

  2008-07-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000145019PMID 18663319
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Somatropin Therapy for Children with Prader- Willi Syndrome

  2006cited by this paper
• Reference data for bone density and body composition measured with dual energy x ray absorptiometry in white children and young adults

  2002cited by this paper
• Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study.

  2002influential reference
• Bone metabolism markers and bone mass in healthy pubertal boys and girls

  2002cited by this paper
• Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH.

  2001cited by this paper
• Growth Hormone Normalises Height, Prediction of Final Height and Hand Length in Children with Prader-Willi Syndrome after 4 Years of Therapy

  2000cited by this paper
• Spontaneous growth in German children and adolescents with genetically confirmed Prader‐Willi syndrome

  2000cited by this paper
• Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.

  2000cited by this paper
• Growth Hormone Treatment of Children with Prader-Willi Syndrome: Effects on Glucose and Insulin Homeostasis

  1999cited by this paper
• Genetic abnormalities in Prader‐Willi syndrome and lessons from mouse models

  1999cited by this paper
• Growth hormone treatment of children with Prader‐Willi syndrome affects linear growth and body composition favourably

  1998influential reference
• Reference values for height and weight in Prader-Willi syndrome based on 315 patients

  1998cited by this paper
• Treatment with human growth hormone in patients with Prader-Labhart-Willi syndrome reduces body fat and increases muscle mass and physical performance

  1998influential reference
• Low insulin, IGF-I and IGFBP-3 levels in children with Prader-Labhart-Willi syndrome

  1998cited by this paper
• Peculiar body composition in patients with Prader-Labhart-Willi syndrome.

  1997cited by this paper
• Prader—Willi syndrome and the hypothalamus

  1997cited by this paper
• Sex steroids, growth hormone, insulin-like growth factor-1: neuroendocrine and metabolic regulation in puberty.

  1996cited by this paper
• Cross sectional stature and weight reference curves for the UK, 1990.

  1995cited by this paper
• Body mass index reference curves for the UK, 1990.

  1995cited by this paper
• Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases.

  1995cited by this paper
• Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index.

  1994cited by this paper
• Comparisons between Hologic, Lunar and Norland dual-energy X-ray absorptiometers and other techniques used for whole-body soft tissue measurements.

  1994cited by this paper
• Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand.

  1991cited by this paper
• Monoclonal antibodies reveal circulating growth hormone of high molecular weight not detectable by conventional assays.

  1990cited by this paper
• Prader‐Willi Syndrome and Scoliosis

  1981cited by this paper
• The somatic development of children in a swedish urban community.

  1976cited by this paper

• Early-onset growth hormone treatment in Prader–Willi syndrome attenuates transition to severe obesity

  2025cites this paper
• Long-term growth hormone effects in Prader-Willi syndrome

  2025cites this paper
• A contemporary treatment regimen normalizes muscle mass and adult height in children with Prader-Willi syndrome - a longitudinal analysis

  2025cites this paper
• The Effects of Growth Hormone Treatment Beyond Growth Promotion in Patients with Genetic Syndromes: A Systematic Review of the Literature

  2024cites this paper
• Growth hormone treatment in children with Prader–Willi syndrome: safety and effectiveness data from the PATRO Children study

  2024cites this paper
• Safety and Effectiveness of a Biosimilar Recombinant Human Growth Hormone in Children Requiring Growth Hormone Treatment: Analysis of Final Data from PATRO Children, an International, Post-Marketing Surveillance Study

  2024cites this paper
• Clinical Characteristics of Short-Stature Patients With Collagen Gene Mutation and the Therapeutic Response to rhGH

  2022cites this paper
• Molecular Classes and Growth Hormone Treatment Effects on Behavior and Emotion in Patients with Prader–Willi Syndrome

  2022cites this paper
• Long-Term Growth Hormone Treatment of Children with PWS: The Earlier the Start, the Better the Outcomes?

  2022cites this paper
• Endocrine disorders in Prader-Willi syndrome: a model to understand and treat hypothalamic dysfunction.

  2021cites this paper
• Incidence of strabismus, strabismus surgeries, and other vision conditions in Prader-Willi syndrome: data from the Global Prader-Willi Syndrome Registry

  2021cites this paper
• Respiratory system abnormalities in Prader-Willi syndrome: a literature review

  2021cites this paper
• Is strength training feasible for young people with Prader-Willi syndrome? A phase I randomised controlled trial.

  2020cites this paper
• Clinical spectrum and management of imprinting disorders

  2020cites this paper
• Early start of growth hormone is associated with positive effects on auxology and metabolism in Prader-Willi-syndrome

  2020cites this paper
• Growth hormone treatment in Prader-Willi syndrome patients: systematic review and meta-analysis

  2020cites this paper
• GH and IGF-1 Replacement in Children.

  2020cites this paper
• Children Obesity, Glucose Tolerance, Ghrelin, and Prader Willi Syndrome

  2019cites this paper
• Early Diagnosis in Prader–Willi Syndrome Reduces Obesity and Associated Co-Morbidities

  2019cites this paper
• Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled trial

  2019cites this paper
• The associations between diet and physical activity with body composition and walking a timed distance in adults with Prader–Willi syndrome

  2018cites this paper
• Newborn screening for Prader–Willi syndrome is feasible: Early diagnosis for better outcomes

  2018cites this paper
• Growth Hormone Treatment in Children With Prader-Willi Syndrome: Three Years of Longitudinal Data in Prepubertal Children and Adult Height Data From the KIGS Database

  2017cites this paper
• Chapter 28 – Genetic Syndromes Associated with Obesity∗

  2016cites this paper
• Growth Charts for Prader-Willi Syndrome During Growth Hormone Treatment

  2016cites this paper
• New Treatment Perspectives in Prader-Willi syndrome

  2016cites this paper
• Diagnosis and treatment of GH deficiency in Prader-Willi syndrome.

  2016cites this paper
• Growth hormone therapy for Prader–willi syndrome: challenges and solutions

  2016cites this paper
• Growth Hormone Therapy in Adults with Prader-Willi Syndrome

  2015cites this paper
• Kasvuhormoonravi saanud laste kliiniline kirjeldus ja ravi efektiivsus – Tartu Ülikooli Kliinikumi lastekliiniku viimase 12 aasta kogemus

  2015cites this paper
• Hormone replacement therapy in children: The use of growth hormone and IGF-I.

  2015cites this paper
• Growth Hormone Treatment in Children with Prader-Willi Syndrome : From infancy to adulthood

  2015cites this paper
• Growth Charts for Non-Growth Hormone Treated Prader-Willi Syndrome

  2015cites this paper
• Bone mineral density in children and adolescents with Prader-Willi syndrome: a longitudinal study during puberty and 9 years of growth hormone treatment.

  2015cites this paper
• Growth hormone secretion decreases with age in paediatric Prader‐Willi syndrome

  2015cites this paper
• Obesity management in Prader-Willi syndrome.

  2015cites this paper
• Особенности ожирения и метаболических нарушений при синдроме Прадера-Вилли у детей

  2014cites this paper
• Growth Hormone Therapy, Muscle Thickness, and Motor Development in Prader-Willi Syndrome: An RCT

  2014cites this paper
• Syndromic Disorders with Short Stature

  2014cites this paper
• Cutaneous vasculitis in patients with autoimmune polyendocrine syndrome type 1: report of a case and brief review of the literature

  2014cites this paper
• Growth and Growth Hormone Use in Osteogenesis Imperfecta

  2014cites this paper
• GROWTH FAILURE IN CHILDREN WITH END STAGE RENAL FAILURE ASSOCIATED ADRENOGENITAL SYNDROME

  2014cites this paper
• Response to growth hormone treatment in Prader–Willi syndrome: Auxological criteria versus genetic diagnosis

  2013cites this paper
• endocrine management of children with Prader-willi syndrome

  2013cites this paper
• Growth Hormone Therapy in Children with Prader-Willi Syndrome

  2013cites this paper
• Treatment of children and adolescents with idiopathic short stature

  2013cites this paper
• Eight years of growth hormone treatment in children with Prader-Willi syndrome: maintaining the positive effects.

  2013cites this paper
• Growth hormone combined with child-specific motor training improves motor development in infants with Prader-Willi syndrome: a randomized controlled trial.

  2013cites this paper
• Effects of growth hormone treatment in adults with Prader-Willi syndrome.

  2013cites this paper
• Two years of growth hormone treatment in adults with Prader-Willi syndrome do not improve the low BMD.

  2013cites this paper
• Growth Hormone Research Society Workshop Summary: Consensus Guidelines for Recombinant Human Growth Hormone Therapy in Prader-Willi Syndrome

  2013cites this paper
• Growth hormone therapy for children and adolescents with Prader-Willi syndrome is associated with improved body composition and metabolic status in adulthood.

  2013cites this paper
• Growth in Prader–Willi Syndrome: Anthropometric Patterns and Analysis

  2012cites this paper
• Outcomes of adenotonsillectomy in patients with Prader-Willi syndrome.

  2012cites this paper
• Transition care of patients with growth hormone deficiency from pediatric endocrinologists to adult endocrinologists.

  2012cites this paper
• Cutaneous manifestations of Prader-Willi syndrome.

  2012cites this paper
• Normal and Aberrant Growth

  2011cites this paper
• Growth hormone secretory pattern in non-obese children and adolescents with Prader-Willi syndrome

  2011cites this paper
• rhGH safety and efficacy update.

  2011cites this paper
• Children Obesity, Glucose Tolerance, Ghrelin, and Prader-Willi Syndrome

  2011cites this paper
• Specific treatment of Prader–Willi syndrome through cyclical rehabilitation programmes

  2011cites this paper
• Prader-Willi syndrome: A primer for clinicians

  2011cites this paper
• Prader–Willi syndrome and growth hormone treatment in children and adults

  2010cites this paper
• Specialty drugs for the treatment of short stature in children-pros, cons, and perspectives for the future

  2010cites this paper
• Diseases of the Hypothalamus and the Pituitary Gland

  2010cites this paper
• Current indications for growth hormone therapy for children and adolescents.

  2010cites this paper
• Systematic Review of the Clinical Effectiveness of Genotropin (Somatropin) in Children with Short Stature

  2010cites this paper
• Síndrome de Prader-Willi

  2010cites this paper
• Update in growth hormone therapy of children.

  2010cites this paper
• Effects on Growth and Metabolism of Growth Hormone Treatment for 3 Years in 36 Children with Prader-Willi Syndrome

  2010cites this paper
• Long-term growth hormone therapy changes the natural history of body composition and motor function in children with prader-willi syndrome.

  2010cites this paper
• Bioequivalence Studies of Omnitrope, the First Biosimilar/rhGH Follow‐on Protein: Two Comparative Phase 1 Randomized Studies and Population Pharmacokinetic Analysis

  2010cites this paper
• Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.

  2010cites this paper
• CE‐ESI‐TOF/MS for human growth hormone analysis

  2010cites this paper
• Inclusion of chiropractic care in multidisciplinary management of a child with Prader-Willi syndrome: a case report.

  2009cites this paper
• Benefit of Early Commencement of Growth Hormone Therapy in Children with Prader-Willi Syndrome

  2009cites this paper
• Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.

  2009cites this paper
• Störungen im Bereich des Hypothalamus und der Hypophyse

  2009cites this paper
• Prader–Willi syndrome: clinical features and management

  2009cites this paper
• Adolescent type 1 diabetes : Eating and gastrointestinal function

  2009cites this paper